Application Of PRP Technology In Premature Ovarian Failure (Literature Review)
Keywords:
premature ovarian insufficiency, PRP therapy, plateletsAbstract
This article presents a review of current scientific data on the use of PRP therapy in the management of premature ovarian insufficiency. The review addresses the main pathophysiological mechanisms of POI, clinical manifestations, and limitations of existing therapeutic approaches. Particular attention is given to the biological effects of PRP mediated by platelet-derived growth factors, including stimulation of angiogenesis, reduction of apoptosis, activation of dormant follicles, and improvement of ovarian reserve indicators. The results of preclinical and initial clinical studies are analyzed, along with potential limitations associated with the lack of standardized protocols for PRP application. The necessity for further randomized controlled trials and standardization of treatment protocols is emphasized to justify the clinical implementation of PRP in gynecological practice.
References
1. Ахмеров Р. Р. Регенеративная медицина на основе аутологичной плазмы // Литтерра. 2014. С.
45-48.
2. Глыбочко П. В., Аляев Ю. Г., Чалый М. Е., Епифанова М. В., Краснов А. О. Применение
клеточных технологий в андрологической практике // Урология. №1. 2016. С. 89-91.
3. Глыбочко П. В., Аляев Ю. Г., Чалый М. Е., Епифанова М. В., Переверзина Н. О., Артеменко С.
А. Клеточные технологии в лечении мужского бесплодия, обусловленного необструктивной
азооспрермией // Урология. 2017. С. 74-77.
4. Aghajanova L., Houshdaran S., Balayan S., Manvelyan E., Irwin JC., Huddleston HG., Giudice LC.
In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial
regeneration // Journal of assisted reproduction and genetics. 2019. P.757-770.
5. Ahmadian S., et al. Platelet-rich plasma in ovarian torsion: effects on follicle reserve, angiogenesis,
and fertility in a rat model of premature ovarian insufficiency // Reproductive Biology and
Endocrinology (RB&E). 2020. P. 47-51.
6. Andia I., Abate M. Platelet-rich plasma: underlying biology and clinical correlates // Regenerative
Medicine. 2013. P.645–658.
7. Au A.E. et al. P2Y12 receptor in platelet activation // Platelets. №7 2021. P. 789–798.
8. Bakacak M., et al. Protective effect of platelet-rich plasma on experimental ischemia/reperfusion injury
in rat ovary // Gynecologic and Obstetric Investigation. 2015. P. 120-125.
9. Barrenetxea G., Celis R., Barrenetxea J., Martínez E., De Las Heras M. Effect of intra-ovarian injection
of platelet-rich plasma on the patients with a poor ovarian response (POR) or premature ovarian
insufficiency (POI): a systematic review and meta-analysis // Middle East Fertil Soc J. 2024 №29. P.
24–41.
10. Bir S.C. et al. Platelet-rich plasma: preparation and formulation // Operative Techniques in
Orthopaedics. 2012. № 4. P. 245–250.
11. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates // Blood reviews.
2019. P.177–189.
12. Bolton-Maggs P.H. et al. Gray platelet syndrome // Haematologica. № 12. 2011. P. 1790–1798.
13. Callejo J. et al. Autologous platelet-rich plasma as a strategy to improve ovarian transplant survival: A
pilot study // Journal of Ovarian Research. № 1 2017. P. 36.
14. Chang Y., Li J., Chen Y., Wei L., Yang X., Shi Y. Autologous platelet-rich plasma promotes endometrial
growth and improves pregnancy outcome during in vitro fertilization // Int J Clin Exp Med. 2015 №1.
P. 128.
15. Craciunas L., Gallos I., Chu J., Bourne T., Quenby S., Brosens J.J., Coomarasamy A. Conventional
and modern markers of endometrial receptivity: a systematic review and meta-analysis // Human
Reprod Update. 2019 №2. P. 202–223.
16. Cremonesi F., et al. Evaluation of intraovarian platelet-rich plasma administration on oocytes and
embryos in superovulated cows // Theriogenology. 2020. P. 63-66.
17. Dawood, A. S., Salem, H. A. Current clinical applications of platelet-rich plasma in various
gynecological disorders: An appraisal of theory and practice. // Clinical and experimental reproductive
medicine. 2018. P. 67–74
18. Everts P. A., Knape J. T., Weibrich G., Schönberger J. P., Hoffmann J., Overdevest E. P., Box H. A.,
van Zundert A. Platelet-rich plasma and platelet gel: a review // The journal of extra-corporeal
technology. 2016. P.174–187.
19. Farimani M, Bahmanzadeh M, Poorolajal J. A new approach using autologous platelet-rich plasma
(PRP) to treatiInfertility and to improve population replacement rate // J Res Health Sci. 2016. P. 120-
122.
20. Farimani M., Heshmati S., Poorolajal J., Bahmanzadeh M. A report on three live births in women with
poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP) // Molecular
biology reports. 2019. P. 1611–1616.
21. Golebiewska E.M. et al. Platelet secretion: from haemostasis to wound healing and beyond // Platelets.
№ 7. 2015. P. 577–585.
22. Heijnen, H. et al. Activated platelets release two types of membrane vesicles: microvesicles and
exosomes // Blood. 2019. №11. P. 3791–3795.
23. Herlihy N.S., Cakiroglu Y., Whitehead C., Reig A., Tiras B., Scott R.T. Platelet-rich plasma (PRP)
treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in
diminished ovarian reserve patients: a systematic review and meta-analysis // J Ovarian Res. 2024
№17. P. 104.
24. Hosseini, L. et al. Platelet-rich plasma promotes the development of isolated human primordial and
primary follicles to the preantral stage // Reproductive BioMedicine Online № 5. 2017. P. 523–530.
25. Javaheri A., Kianfar K., Pourmasumi S., Eftekhar M. Platelet-rich plasma in the management of
Asherman's syndrome: An RCT // International journal of reproductive biomedicine. 2020. P.113–120.
26. Lana J.F., et al. Platelet rich plasma and its growth factors: the state of the art // Clinical Experience.
2014. P.1-59.
27. Lin Y., Qi J., Sun Y. Platelet-rich plasma as a potential new strategy in the endometrium treatment in
assisted reproductive technology // Front Endocrinol. 2021 №12. P. 70-75.
28. Maged A.M., Mohsen R.A., Salah N., Ragab W.S. The value of intraovarian autologous platelet rich
plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and metaanalysis // BMC Pregnancy Childbirth. 2024 №24. P. 85.
29. Maleki-Hajiagha A., Razavi M., Rouholamin S., Rezaeinejad M., Maroufizadeh S., Sepidarkish M.
Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction:
A systematic review and meta-analysis // J Reprod Immunol. 2020 №137. P. 103.
30. Moustakli E., Potiris A., Zikopoulos A., Zachariou A., Topis S., Panagopoulos P., Domali E., Drakakis
P., Stavros S. Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP
Therapy in Low-Reserve and Premature Ovarian Insufficiency // Biomedicines. 2025 №5. P. 1257.
31. Noronha J.C. Platelet-rich plasma // Clinical Experience. 2014. P.203-213.
32. Pantos, K. et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women
after autologous platelet-rich plasma treatment // Case Reports in Reproductive Medicine. 2016. P.
123.
33. Perez A.G., et al. Challenges and a feasible strategy for studies and standardization of platelet-rich
plasma // International journal of reproductive biomedicine 2014. P.119-138.
34. Roberts L.M., Herlihy N., Reig A., Titus S., Garcia-Milian R., Knight J., Yildirim R.M., Margolis C.K.,
Cakiroglu Y., Tiras B., Whitehead C.V., Werner M.D., Seli E. Transcriptomic landscape of cumulus
cells from patients <38 years old with a history of poor ovarian response (POR) treated with plateletrich plasma (PRP) // Aging (Albany NY). 2025 №2. P. 431–447.
35. Rodrigues A.A., et al. Platelet-rich plasma and tissue engineering // Biology. 2014. P. 139-151.
36. Sclafani А. Safety, efficacy and utility of platelet-rich fibrin matrix in facial plastic surgery // Arch
Facial Plast Surg. 2011 P.14-19.
37. Sills, E.S. et al. First data from the GENESA study using autologous PRP therapy for ovarian
insufficiency // Journal of Regenerative Medicine. № 1. 2019.– P. 153.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Texas Journal of Multidisciplinary Studies
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
